William F. Doyle, Executive Chairman at NovoCure Ltd (NVCR), sold 1,674 shares at $69.66 ($117K) on 2022-08-02, disclosed to the SEC on 2022-08-03.
Seasonal sale ($117k) by Executive Chairman — this insider has traded NVCR in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $69.66 | 837 | $58K | 50.0% |
| 2 | $69.66 | 837 | $58K | 50.0% |
| Total | $69.66 avg | 1,674 | $117K | 100% |
| Filing → |
| ELAN | BUY | 2024-03-12 | $245K | — | Filing → |
| NVCR | SELL | 2022-03-09 | $334K | — | Filing → |
| NVCR | SELL | 2021-08-04 | $297K | — | Filing → |